What Is PCT National Phase Entry? A Plain-English Guide for Founders

1. Overview

When a founder hears “international patent,” the expectation is simple:
“I want to protect my product in more than one country.”

Unfortunately, the legal system is not that simple. There is no single “global patent.” Instead, there are:

Local and regional patent offices, each with its own law and procedure.
An international system (the PCT) that connects them.

“PCT national phase entry” is the bridge between the international part and the country-by-country part.

In practical terms, this is the stage where:

A single international application is converted into a set of national or regional patent applications.
Real money starts getting spent in each country.
Strategic decisions about markets, budgets, and long-term protection become unavoidable.

This guide aims to give you a clear picture of what PCT national phase entry is, why the timing matters, how it affects your business decisions, and which questions you should be asking your patent counsel or service providers.

You do not need to be a patent expert to understand this. If you know your business and markets, you can understand the basics of the system well enough to make informed, confident decisions.

2. Who this guide is for

Different people look at PCT national phase entry through different lenses. This guide is written to be useful for all of them.

Founders and business owners

You may have:

Filed a first patent application in your home country.
Heard your lawyer talk about “filing a PCT.”
Been told you have to “enter national phase” around 30–31 months.

You do not want to learn the full patent law syllabus. You want to know:

What decisions are coming up.
How those decisions affect budget, risk, and valuation.
What can go wrong if you delay or choose badly.

This guide will give you a structured view, plus a checklist you can use in internal discussions.

In-house legal and strategy teams

If you work in-house, you already know the basics of patents. Your challenge is often:

Translating legal timelines into business timelines.
Explaining costs and trade-offs to leadership.
Keeping dozens of cases and countries on track.

This guide can help as a shared reference you can circulate internally, especially to product, finance, and leadership teams who need a simple but accurate explanation of the PCT journey.

Law students and junior professionals

If you are studying IP or just starting in practice, PCT procedures can feel abstract. This guide aims to:

Connect procedural rules to real-world business decisions.
Provide examples you can visualise.
Offer a neutral, structured explanation you can build on when you later dive into detailed rules or national laws.

3. Quick refresher: What is the PCT?

The Patent Cooperation Treaty (PCT) is an international agreement that links many patent offices around the world. It does not replace them. It does not grant patents. It provides a common first step.

A practical way to think of the PCT is:

One international application that keeps your options open in many countries, for a limited period, while giving you an early technical and legal assessment.

What the PCT does

When you file a PCT application:

You claim the benefit of your first filing (the priority application).
You get an international search report that lists prior art documents related to your invention.
You receive a written opinion with a preliminary view on novelty, inventive step, and industrial applicability.
Your application is published and becomes part of the public record.
You gain time (up to about 30–31 months from the priority date) before you must file in individual countries or regions.

This phase is largely about information and timing. You learn about the strength of your invention, your competitors’ prior art, and your own business traction while keeping the door open to multiple jurisdictions.

What the PCT does not do

The PCT does not:

Grant you a patent in any country.
Give you an enforceable worldwide right.
Guarantee that any national office will grant a patent later.

Each national or regional office will eventually decide under its own law whether to grant or refuse a patent, even though they can see and use the international search report.

Why the distinction matters

Many non-lawyers casually say “PCT patent” as if it is a special kind of patent. It is not. It is a stage in the process.

Understanding this difference helps you see national phase entry correctly:

The PCT is the “single, international application and assessment” phase.
National phase entry is “now we go country by country and try to get actual patents.”

4. What is “national phase entry”?

National phase entry is the step where your PCT application stops being a single international file and becomes multiple local files.

Imagine your PCT application as a tree trunk. National phase entry is when you let that trunk branch out into separate limbs:

One branch for the United States
One for Europe
One for India
One for China
And so on

Each branch grows independently after that point. One branch might flourish (grant). Another might be pruned (refused or narrowed). All are rooted in the same PCT “trunk,” but their fate is separate.

What actually happens at national phase entry

For each chosen country or region, you (usually through a local attorney or agent):

File the necessary forms and submit the PCT application details to that office.
Provide translations if required.
Pay official fees and any initial attorney fees.
File any claim amendments you want to make at entry.

From the patent office’s point of view, they now have a local application that is linked back to the PCT number and priority date. From your point of view, you now have one more individual file to track.

National vs regional phase

Some offices are national (for example, the United States Patent and Trademark Office, the Indian Patent Office). Others are regional (for example, the European Patent Office).

Entering a national phase gives you one country.
Entering a regional phase can eventually give you protection in multiple countries within that region, depending on what you validate and where you pay fees.

For planning, it is helpful to treat both as “national phase entry,” because in both cases you are converting the international application into one or more enforceable rights in specific territories.

5. The patent journey in three stages

To avoid getting lost in detail, it helps to keep one simple mental picture: the journey runs in three main stages. Each stage has its own questions and decisions.

Stage 1: Priority or first filing (day 0–12 months)

This is where you “plant the flag.”

You file the first patent application in your home country or another chosen office.
This filing sets the priority date, which acts as a reference point for most later deadlines.
Anything publicly disclosed before this date can count as prior art against you. Anything after is usually less of a problem (with some country-specific nuances).

From a founder’s point of view, this stage is about:

Making sure the invention is described with enough technical detail.
Ensuring the core features that matter to the business are covered.
Avoiding unnecessary public disclosures before filing.

Stage 2: International (PCT) phase (up to about 30–31 months)

This is the “hold and learn” stage.

Key events:

You file a PCT application within 12 months of the priority date.
The application is searched and later published.
You receive an international search report and written opinion.
You have time to watch how your product and markets evolve.

The business questions in this stage include:

Does the search report show serious prior art problems, or is the field relatively clear?
How important has this invention turned out to be compared to your other projects?
Where is revenue coming from, or expected to come from?
Are investors, partners, or potential acquirers signalling that patents in certain regions are especially important?

Ideally, you use this stage to start shaping a “shortlist” of countries based on both legal strength and business value.

Stage 3: National or regional phase (around 30–31 months onward)

This is the “commit and execute” stage.

You decide which countries or regions to enter.
You instruct local attorneys or a coordinating firm.
Each office examines your application separately and may grant or refuse a patent.
Costs become more visible and spread over many files.

Business and legal teams at this stage should be aligned on:

Which territories are must-have, optional, or to be dropped.
What total cost envelope is acceptable over the next 5–10 years.
How the portfolio will be managed and who will be responsible for tracking deadlines and decisions.

If you keep this three-stage picture in mind as you read the rest of the guide, the terminology becomes much easier to follow and the “national phase” feels less like a mysterious legal step and more like a natural, planned transition in the patent journey.

6. Key deadlines: 12 months, 18 months, 30–31 months

The PCT system is built around a few anchor dates. If you remember these three, you will understand most of the timing pressure.

Priority date – the starting point

Everything is counted from the priority date:

Usually the filing date of your first patent application for that invention.
Acts as the reference point for novelty: most prior art before this date can be used against you; most after cannot.

Think of it as “Day 0” in your patent calendar.

12 months – the priority window

You normally have 12 months from the priority date to:

File a PCT application that claims priority from the first filing.
Or file foreign applications in individual countries directly (Paris route).

If you miss this window, you may:

Lose the right to rely on the earlier filing date in other countries.
End up in a weaker position if there have been any disclosures or filings after that first date.

For founders, this means:

Plan the PCT decision well before month 12, not one week before.
If you expect to need foreign protection, budget and instructions should be ready by month 9–10.

Around 16–18 months – international search and publication

Between months 16 and 18 (approximate, can vary):

The international search report and written opinion are issued.
Around 18 months from priority, your application is published.

This is important because:

You get your first formal feedback on how strong the invention looks.
The world now sees your application; competitors and investors can read it.

This is a good time to:

Revisit your product roadmap and see if the patent still matches where the product is going.
Start very early thinking about which markets seem promising enough to justify national phase costs.

30–31 months – national or regional phase entry

For most PCT member states:

You must enter national or regional phase by a deadline around 30 or 31 months from the priority date.
Some offices use 30 months; some 31; a few have special or earlier deadlines.

If you miss a country’s deadline:

In some places, there are strict, limited mechanisms for late entry, typically with extra fees and conditions.
In others, rights are simply lost and cannot be revived.

Because of this, many companies work with an internal “soft” deadline earlier than the official one:

For example, aim to finalise country list and internal approvals by 26–27 months.
Leave the final few months for translations, paperwork, and unexpected delays.

Putting it together in practice

A healthy internal timeline might look like this:

Up to 12 months: decide whether to file a PCT.
16–18 months: review search report and written opinion; start early thinking on markets.
18–24 months: refine the business case for each major region; build cost scenarios.
24–28 months: shortlist and then finalise countries; confirm budget and providers.
Before 30–31 months: file national/regional phase entries in each chosen jurisdiction.

If you treat deadlines as stages in a long, planned process rather than last-minute surprises, national phase entry becomes manageable instead of overwhelming.

7. Why founders use the PCT national phase route

Founders do not choose the PCT route because they love procedures. They choose it because it helps them manage uncertainty.

You are almost always uncertain about three things early on:

Where your business will actually grow.
How strong your invention really is.
How much budget you can justify for patents.

The PCT national phase route gives you tools to manage those unknowns.

Buying time without losing rights

If you filed directly in multiple countries within 12 months, you would have to:

Decide on your entire global strategy very early.
Commit to substantial costs before you know much about traction or competition.

With the PCT route:

You make a single international filing.
You can delay the detailed, expensive country decisions to 30–31 months.

That extra year and a half can make a big difference:

A product that was an idea at month 12 may be live and generating data at month 30.
Investor feedback, pilot customers, and competitor actions are clearer.
You may have raised capital or reprioritised your portfolio.

Getting an early quality signal

The international search report and written opinion give you:

A structured list of prior art documents.
An initial legal view on whether your claims seem novel and inventive.

This is not a guarantee of success or failure, but it is more than guesswork. It can:

Confirm that your invention is distinctive enough to justify broad protection.
Reveal serious prior art that might make the case weaker or narrower than you hoped.

Armed with this, you can:

Channel budget into cases that look strong.
Consider dropping or narrowing cases that look weak.
Adjust claims before you start facing multiple national examiners.

Aligning patents with real markets

By the time you are planning national phase entry:

You may know which countries already have paying customers.
Sales and marketing teams have targets by region.
Manufacturing locations and supply chains are more stable.
Competitors may have started moving in specific territories.

This allows a more realistic conversation:

Do we really need protection in 15 countries, or is 5 enough?
Which regions are mission-critical for revenue or exit valuation?
Where is the risk of copycats high, and is enforcement practical there?

Without the PCT system, you would have to make similar calls with far less information and much earlier.

Managing budget and cash flow

Patents are long-term investments. The PCT national phase route helps you spread the financial impact:

Initial cost at first filing.
Additional cost at PCT filing.
Major chunks of cost only when entering national phase in chosen countries.

This staggered pattern can be easier to manage than a sudden, large multi-country filing within 12 months. It also gives you clear points at which you can decide to accelerate, maintain, or cut back on investment.

8. What decisions you must make before entering national phase

As you approach 30–31 months, the goal is not merely to “file everywhere we can.” The goal is to make deliberate decisions that connect legal protection to business value.

You can think of the decisions in four layers: invention, geography, budget, and execution.

1. Invention: which cases still matter?

Start by looking at your portfolio, not just the PCT in isolation.

Ask:

Is this invention still central to our product or technology roadmap?
Has the product pivoted so much that the original claims now capture only a small part of what matters?
Are there newer filings that better protect our current direction?

Possible outcomes:

Continue: proceed to national phase because the invention remains core.
Narrow: continue but maybe only in fewer, key markets.
Drop: do not enter national phase if the invention is clearly no longer aligned with the business.

Dropping a case can be a positive decision if it frees budget and attention for more relevant filings.

2. Geography: where does protection create real value?

For each invention that survives the first filter, look at geography.

Consider:

Revenue and growth: where do you currently sell and where do you expect growth?
Manufacturing and logistics: where is the product made, assembled, or warehoused?
Competitors: where are the main competitors based or particularly active?
Enforcement environment: where is the legal and practical environment reasonably supportive if you need to enforce?

You can make a simple rating for each region or country:

Business importance: low, medium, high.
Copy risk: low, medium, high.
Enforcement feasibility: low, medium, high.
Cost level: low, medium, high.

Even a rough scoring like this helps you see which countries truly sit in the “must-have” zone.

3. Budget: how much can you actually sustain?

Once you have a sense of geography, reality needs to meet ambition.

Questions to ask:

What is our total budget for this invention over the next 5–10 years?
How much of that can we commit now, at national phase entry?
Are we willing to adjust the country list if costs, exchange rates, or internal priorities change?

It may help to prepare a few scenarios, for example:

Lean scenario: protect only in 2–3 key territories.
Balanced scenario: include a few more strategic markets.
Expansive scenario: protect in most markets where revenue or strategic interest is expected.

Having these scenarios in advance makes it easier to adjust quickly if management or investors change priorities.

4. Execution: who will do the work and how?

Finally, you need to decide how the work will be carried out.

Options include:

One coordinating firm that manages foreign associates and invoices.
A mix of trusted firms in a few key jurisdictions.
A marketplace or platform where multiple local providers can quote and you choose based on cost, expertise, and service.

Practical points:

Who will be the internal owner for tracking deadlines and instructions?
How will you store and share documents securely with multiple firms?
How will you keep a consolidated view of cost and status across all countries?

Clear answers at this stage reduce friction and confusion once the filing rush starts.

9. High-level cost picture (without country-specific numbers)

Every founder asks sooner or later: “How much will this cost?”

The honest answer is “it depends,” but you can understand the structure even without exact figures. That structure is similar across most jurisdictions.

Main cost categories

You can break national phase cost into three main layers.

Filing and formalities (upfront)
Prosecution (responses and amendments over time)
Maintenance (renewal or annuity fees after grant)

Within each layer, you have both government fees and professional fees.

Filing and formalities

Typical components:

Official filing fees: often depend on
- Number of claims
- Number of pages
- Entity size (small entity discounts in some jurisdictions)
Translation costs: if your PCT language differs from the local language. For long specifications, this can be one of the largest initial items.
Local professional fees: for filing, checking formalities, and handling power of attorney, assignments, forms, and correspondence.

These are usually “front-loaded” at or around the time you enter national phase.

Prosecution

After filing, most patent offices will raise one or more examination issues:

Objections on novelty, inventive step, or clarity.
Requests to amend claims.
Formality objections, for example about naming or priority claims.

Costs here come from:

Local attorneys analysing the examiner’s report.
Drafting responses and amendments.
Filing the responses and managing deadlines.
Paying any further official fees (for excess claims, continued examination, extensions of time, and so on).

These costs are spread over several years. They are harder to predict precisely, but you can work with typical ranges based on past experience or guidance from your advisors.

Maintenance

If a patent is granted, the cost does not end there. Almost all jurisdictions require periodic payments to keep the patent alive:

These can be annual or at specified intervals.
Fees often rise in later years.

Maintenance decisions are an opportunity to prune the portfolio:

Continue paying for countries where the patent still supports real business value.
Allow patents to lapse in countries where the product has been discontinued or the market never developed.

Thinking in terms of “cost over lifetime”

Instead of asking only “What will national phase entry cost this year?”, try to think of:

Estimated total cost over 10 years for each country.
How that compares to expected revenue, strategic value, or risk avoided in that country.

For example:

It may be reasonable to maintain an expensive patent in a country that generates meaningful revenue or is crucial for exit valuation.
It may not be sensible to keep paying renewals in a territory where you have no sales and no realistic enforcement plans.

This long view helps avoid two extremes:

Over-investing in patents that will never be used in practice.
Under-investing in key markets because only short-term costs were considered.

10. Step-by-step: what actually happens when you enter national phase

From the outside, “enter national phase” sounds like a single action. In reality, it is a sequence of small, concrete steps repeated across multiple countries.

You can picture it as the same workflow running in parallel, with country-specific variations.

Step 1: Confirm instructions and strategy

Before anyone starts filing:

The responsible lawyer or coordinator summarises the planned countries, key deadlines, and any initial claim strategy.
Management confirms the list and budget.
Any country that looks uncertain is resolved now, not on the last day.

This is also the moment to decide whether any claim amendments will be made at entry, for example:

Narrowing claims to align with the search report.
Harmonising claims to better fit local practice in challenging jurisdictions.

Step 2: Engage local representatives

For each chosen country or regional office:

A local patent attorney or agent is identified (or confirmed, if already known).
They receive the necessary details:
- PCT application number
- Priority details
- Current specification and claims
- Any preferred claim amendments
- Applicant and inventor information

If you use a coordinating firm or marketplace, they may handle this communication centrally.

Step 3: Prepare documents and translations

The local representative then:

Prepares the local filing forms.
Identifies which parts of the application need translation, if any.
Advises on specific requirements, such as:
- Signature formats
- Legalisation or notarisation of certain documents
- Local address for service

On your side, you may need to:

Approve or provide translations (or approve the cost of translation).
Sign powers of attorney or other forms.
Confirm the exact legal name and address of the applicant entity for each jurisdiction.

Starting this early reduces the risk that minor paperwork issues will push you against the deadline.

Step 4: File and pay official fees

As the deadline approaches, the local attorney will:

File the national or regional phase entry with the patent office.
Pay the official fees required at that stage.
Obtain a local application number or confirmation from the office.

You should receive:

A filing confirmation or copy of the filed forms.
A summary of what was filed, including any claim amendments.
An updated docket of next expected steps and deadlines in that country.

Step 5: Formalities examination

After filing, the office carries out a formalities check:

Are all required documents present?
Are translations complete and in the correct format?
Are the applicant and inventor details consistent?

If something is missing or defective, the office usually issues a notice with a time limit to fix it.

Your role:

Respond promptly when your attorney asks for missing information or signatures.
Approve any necessary corrective filings or additional fees.

Step 6: Substantive examination and ongoing prosecution

Once formalities are in order, the office moves on to substantive examination:

The examiner studies the application and prior art (including the international search report).
One or more examination reports are issued, raising objections or requesting amendments.

Your local attorney will:

Analyse each report.
Propose a response and any claim changes.
Discuss with you, especially if the requested narrowing affects commercial value.

This stage can last several years and is often where strategic decisions on scope, timing, and cost are made.

11. Common myths and mistakes to avoid

National phase entry sits at the intersection of law, strategy, and money. Because of that, a few misunderstandings keep coming up. Clearing them early helps you avoid expensive surprises.

Myth 1: A PCT application is a global patent

A PCT application is not a patent. It is:

An international filing and examination procedure.
A way to keep options open in many countries for a limited time.

You only get enforceable rights when individual national or regional offices grant patents. Until then, you have a pending application, not a guaranteed right.

Why this matters:

Do not assume you are “protected worldwide” just because you filed a PCT.
Investors and partners should understand that the real test still lies ahead in each jurisdiction.

Myth 2: I can always enter national phase later if business picks up

National phase deadlines are real and strict for each country. Once a deadline passes:

Some countries allow late entry with extra fees and a legal explanation.
Others do not, and the opportunity is permanently lost.

Treat national phase entry as a one-time window for each country, not a flexible option you can exercise whenever convenient. If there is a realistic chance a country will be important, decide before the deadline, not after.

Myth 3: If the international search report is negative, the case is dead

A critical international search report can be discouraging, but it is not the final word.

In practice:

Some examiners are more conservative than others.
Some prior art issues can be addressed through claim amendments.
National examiners may interpret the same prior art differently.

A negative report is a reason to think carefully, not to panic. It may lead you to:

Narrow claims.
Focus on fewer countries.
Keep the case alive only in key markets.

Mistake 1: Over-filing in too many countries

Filing in many countries feels safe, but each extra jurisdiction adds:

Filing cost
Translation cost
Ongoing prosecution and maintenance cost
Management and coordination overhead

This can drain resources from other priorities. A portfolio that looks impressive on a map may be unsustainable in real budgets.

A better approach:

Protect strongly where business value is clear.
Be selective elsewhere.
Reassess regularly as the business evolves.

Mistake 2: Under-filing and missing key markets

The opposite risk is being too cautious:

Filing only in a home country when your market, competitors, and likely acquirers are global.
Ignoring regions that are known to be important for your industry, such as the United States and Europe in many tech and life-science sectors.

Missing a key region can:

Reduce bargaining power in negotiations.
Lower the perceived value of the portfolio.
Make it harder to stop copycats in important markets.

A balanced strategy is better than either extreme.

Mistake 3: Leaving decisions to the last month

Pushing national phase planning to the last month before 30–31 months creates avoidable risk:

Translations may be rushed or delayed.
Internal approvals may not be in place.
Local counsel may have little time to advise on claim strategy.

Result:

Stress for everyone involved.
Higher risk of errors or missed deadlines.
Country choices made in a hurry without proper cost–benefit analysis.

Starting structured planning around 24 months gives space to think, compare, and prepare.

12. How strategy differs for different types of companies

Not every company should behave the same way at national phase. The right strategy depends on stage, sector, and business model.

Early-stage startup with limited funds

For an early-stage startup, cash is tight and the future is uncertain.

Likely situation:

Limited revenue.
A few core inventions.
Unclear which markets will ultimately matter.

Possible approach:

Focus on a small set of core markets, often including:
- Home country.
- One or two major markets where customers or acquirers are likely to be.
Avoid filing in countries solely “because everyone does.”
Keep headroom in the budget for product development and operations.

At this stage, patents should support the story you tell investors and partners, not suffocate the business with cost.

Revenue-stage tech company

A company with growing revenue has more data:

Real customers in specific regions.
Clearer view of competitors.
More internal capacity to manage a portfolio.

Possible approach:

Protect key revenue markets strongly.
Add protection in manufacturing hubs and places where competitors are particularly active.
Consider regional strategies (for example, Europe through a regional office) to cover multiple markets efficiently.

Here, patents are one tool among many for consolidating market position and negotiating power.

Deep-tech, pharma, and med-device companies

In these sectors, patents are often central, not peripheral:

Large R&D costs.
Long product development timelines.
Heavy regulatory requirements.

Possible approach:

Treat patent strategy as part of the core business plan.
Invest in strong coverage in major regulatory and market regions from the beginning.
Consider complementary rights such as supplementary protection certificates or data exclusivity where relevant.

Decisions are still bounded by budget, but the threshold for investment is different because the value of strong protection is higher.

Companies contemplating exit or licensing

If you are planning:

A sale of the company, or
A licensing strategy as a revenue model,

then national phase choices should be informed by:

Where likely buyers or licensees operate.
Which jurisdictions they routinely value in due diligence.

In some industries, missing certain countries can be a noticeable weakness in negotiations. It can be better to have strong, focused protection in a smaller set of strategic jurisdictions than thin coverage scattered widely.

13. When to get professional help (and what to ask)

Almost every company benefits from professional guidance at national phase. The challenge is not whether to involve professionals, but how to use them effectively.

When to involve professionals

Good times to seek advice include:

Before filing the first application, to set a long-term view.
Before the 12-month mark, to decide between PCT and direct filings.
Around 18–24 months, to start shaping a national phase strategy.
Before finalising country choices, to test assumptions and understand local quirks.

Waiting until the last few weeks before 30–31 months limits what professionals can do beyond rushing paperwork.

Who can help

Typical options:

The same patent firm that handled your first filing and PCT.
A specialist foreign-filing or international coordination firm.
A marketplace or platform where vetted local firms provide quotes and service profiles.

Your choice may depend on:

Complexity of the portfolio.
Internal capacity to coordinate.
Desire to compare cost and service levels across providers.

Questions to ask your advisor

To make the most of professional help, ask specific questions:

Which countries do you recommend for our business, and why?
Are there any countries you would not recommend for this invention, and why not?
What is your rough estimate of total cost over 10 years for this set of countries?
Are there any unusual local rules or risks we should know about in our chosen jurisdictions?
Can we consider staging entries or using different filing strategies for different regions?
What claim amendments do you recommend at national phase entry, if any?

Clear answers to these questions help align legal decisions with business reality.

How to work well with professionals

You can make the relationship more effective by:

Sharing your business priorities and constraints openly.
Providing timely approvals and information.
Asking for concise written summaries that you can share internally.

A good professional relationship is a partnership, not just a series of instructions.

14. Key terms explained simply

Patent language can be dense. Here are some of the main terms used in this guide, in plain language.

Priority date
The date of your first patent filing for a particular invention. Most later deadlines and rights are counted from here.
Priority application
The first application that sets the priority date. Later filings can “claim priority” from it if done within the allowed time.
PCT (Patent Cooperation Treaty)
An international agreement that lets you file one international application and later use it as a basis for seeking patents in many countries.
PCT application
The international application filed under the PCT. It holds your place in line in multiple jurisdictions and triggers an international search and written opinion.
International search report
A document produced by an International Searching Authority listing prior art documents that appear relevant to your invention.
Written opinion
A preliminary legal view on whether your invention appears novel, inventive, and industrially applicable, based on the search results.
National phase entry
The step where your PCT application is used to file local patent applications in individual countries or regions, within specific deadlines.
Regional phase entry
Similar to national phase entry, but into a regional office (such as the European Patent Office) that can cover multiple countries.
Official fees
Fees charged by patent offices for filing, examination, maintenance, and other services.
Professional or service fees
Fees charged by patent attorneys, agents, or firms for their work in preparing, filing, and prosecuting applications.
Prosecution
The back-and-forth process with the patent office, including examination reports, responses, and amendments, until the application is granted or refused.
Annuities or renewal fees
Periodic payments required to keep a granted patent in force for its full term.

15. Summary checklist for busy founders

If you are short on time and need a quick reference, use this checklist as you move toward national phase.

Understand your starting point
- Note the priority date of your first filing.
- Confirm when the PCT was filed and when it was published.
Map key deadlines
- Record the main 30–31 month national phase deadlines.
- Ask your advisor if any countries of interest have different or earlier deadlines.
Review invention relevance
- Is this invention still central to your product or technology roadmap?
- Are there cases you can drop to save budget and focus?
Analyse geography
- Where are your current and near-term markets?
- Where are products made and shipped from?
- Where are competitors active and enforcement realistic?
Build scenarios
- Prepare a lean, balanced, and expansive country set.
- Discuss each scenario’s 10-year cost and benefits with your advisor.
Confirm budget and priorities
- Decide how much you can invest in this invention over the next 5–10 years.
- Prioritise must-have countries; reconsider marginal ones if budget is tight.
Choose your execution model
- Decide whether to work with a single coordinating firm, a panel of firms, or a marketplace platform.
- Identify a clear internal owner for deadlines and communication.
Start early
- Begin structured planning around 24 months, not at 29.
- Allow time for translations, approvals, and claim strategy discussions.
Track and revisit
- Keep a simple but accurate record of filings, deadlines, and status by country.
- Reassess your portfolio as business conditions change; prune or reinforce as needed.
Keep business and legal aligned
- Ensure patent decisions are discussed with product, sales, and finance teams.
- Treat patents as a strategic tool, not a purely legal checkbox.

With these points in place, PCT national phase entry becomes less of a mystery and more of a structured, manageable step in building a patent portfolio that truly supports your business goals.